Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:2727-2733
Published online before print May 19, 2008, doi: 10.1161/CIRCULATIONAHA.107.740670
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
117/21/2727    most recent
CIRCULATIONAHA.107.740670v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Eckstein, J.
Right arrow Articles by Sticherling, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eckstein, J.
Right arrow Articles by Sticherling, C.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Pacemakers and Implantable Defibrillators
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Ablation/ICD/surgery
Right arrow Pacemaker
Right arrowRelated Article

(Circulation. 2008;117:2727-2733.)
© 2008 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Necessity for Surgical Revision of Defibrillator Leads Implanted Long-Term

Causes and Management

Jens Eckstein, MD; Michael T. Koller, MD; Markus Zabel, MD; Dietrich Kalusche, MD; Beat A. Schaer, MD; Stefan Osswald, MD; Christian Sticherling, MD

From the Division of Cardiology (J.E., B.A.S., S.O., C.S.) and Basel Institute for Clinical Epidemiology (M.T.K.), University Hospital, Basel, Switzerland; Charité-University Hospital Benjamin Franklin, Berlin, Germany (M.Z.); Division of Cardiology, University of Göttingen, Göttingen, Germany (M.Z.); and Herz-Zentrum Bad Krozingen, Bad Krozingen, Germany (D.K.).

Correspondence to Christian Sticherling, MD, FESC, University Hospital Basel, Division of Cardiology, Petersgraben 4, 4031 Basel, Switzerland. E-mail csticherling{at}uhbs.ch

Received September 17, 2007; accepted March 4, 2008.

Background— Defibrillator lead malfunction is a potential long-term complication in patients with an implantable cardioverter-defibrillator (ICD). The aim of this study was to determine the incidence and causes of lead malfunction necessitating surgical revision and to evaluate 2 approaches to treat lead malfunction.

Methods and Results— We included 1317 consecutive patients with an ICD implanted at 3 European centers between 1993 and 2004. The types and causes of lead malfunction were recorded. If the integrity of the high-voltage part of the lead could be ascertained, an additional pace/sense lead was implanted. Otherwise, the patients received a new ICD lead. Of the 1317 patients, 38 experienced lead malfunction requiring surgical revision and 315 died during a median follow-up of 6.4 years. At 5 years, the cumulative incidence was 2.5% (95% confidence interval, 1.5 to 3.6). Lead malfunction resulted in inappropriate ICD therapies in 76% of the cases. Implantation of a pace/sense lead was feasible in 63%. Both lead revision strategies were similar with regard to lead malfunction recurrence (P=0.8). However, the cumulative incidence of recurrence was high (20% at 5 years; 95% confidence interval, 1.7 to 37.7).

Conclusions— ICD lead malfunction necessitating surgical revision becomes a clinically relevant problem in 2.5% of ICD recipients within 5 years. In selected cases, simple implantation of an additional pace/sense lead is feasible. Regardless of the chosen approach, the incidence of recurrent ICD lead-related problems after lead revision is 8-fold higher in this population.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 2719-2720. [Full Text]